Vericel Corporation ATQP.F Stock
Vericel Corporation Price Chart
Vericel Corporation ATQP.F Financial and Trading Overview
| Vericel Corporation stock price | 46.6 EUR |
| Previous Close | 31 EUR |
| Open | 31.2 EUR |
| Bid | 31.2 EUR x 200000 |
| Ask | 31.4 EUR x 200000 |
| Day's Range | 31.2 - 31.2 EUR |
| 52 Week Range | 17.45 - 32.6 EUR |
| Volume | 250 EUR |
| Avg. Volume | 5 EUR |
| Market Cap | 1.48B EUR |
| Beta (5Y Monthly) | 1.772887 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 65.04 EUR |
ATQP.F Valuation Measures
| Enterprise Value | 1.4B EUR |
| Trailing P/E | N/A |
| Forward P/E | 65 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.765238 |
| Price/Book (mrq) | 7.64144 |
| Enterprise Value/Revenue | 8.281 |
| Enterprise Value/EBITDA | -102.374 |
Trading Information
Vericel Corporation Stock Price History
| Beta (5Y Monthly) | 1.772887 |
| 52-Week Change | 45.82% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.6 EUR |
| 52 Week Low | 17.45 EUR |
| 50-Day Moving Average | 29.15 EUR |
| 200-Day Moving Average | 25.92 EUR |
ATQP.F Share Statistics
| Avg. Volume (3 month) | 5 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 47.56M |
| Float | 43.88M |
| Short Ratio | N/A |
| % Held by Insiders | 0.77% |
| % Held by Institutions | 108.62% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -10.10% |
| Operating Margin (ttm) | -10.60% |
| Gross Margin | 66.65% |
| EBITDA Margin | -8.089% |
Management Effectiveness
| Return on Assets (ttm) | -4.44% |
| Return on Equity (ttm) | -9.33% |
Income Statement
| Revenue (ttm) | 169.31M EUR |
| Revenue Per Share (ttm) | 3.59 EUR |
| Quarterly Revenue Growth (yoy) | 13.70% |
| Gross Profit (ttm) | 109.79M EUR |
| EBITDA | -13696000 EUR |
| Net Income Avi to Common (ttm) | -17113000 EUR |
| Diluted EPS (ttm) | -0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 119.28M EUR |
| Total Cash Per Share (mrq) | 2.51 EUR |
| Total Debt (mrq) | 46.88M EUR |
| Total Debt/Equity (mrq) | 24.17 EUR |
| Current Ratio (mrq) | 6.175 |
| Book Value Per Share (mrq) | 4.083 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 22.08M EUR |
| Levered Free Cash Flow (ttm) | 14.59M EUR |
Profile of Vericel Corporation
| Country | Germany |
| State | MA |
| City | Cambridge |
| Address | 64 Sidney Street |
| ZIP | 02139 |
| Phone | 617 588 5555 |
| Website | https://vcel.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 305 |
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Q&A For Vericel Corporation Stock
What is a current ATQP.F stock price?
Vericel Corporation ATQP.F stock price today per share is 46.6 EUR.
How to purchase Vericel Corporation stock?
You can buy ATQP.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vericel Corporation?
The stock symbol or ticker of Vericel Corporation is ATQP.F.
Which industry does the Vericel Corporation company belong to?
The Vericel Corporation industry is Biotechnology.
How many shares does Vericel Corporation have in circulation?
The max supply of Vericel Corporation shares is 49.49M.
What is Vericel Corporation Price to Earnings Ratio (PE Ratio)?
Vericel Corporation PE Ratio is 4660.00000000 now.
What was Vericel Corporation earnings per share over the trailing 12 months (TTM)?
Vericel Corporation EPS is 0.01 EUR over the trailing 12 months.
Which sector does the Vericel Corporation company belong to?
The Vericel Corporation sector is Healthcare.